CDH Investments

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 167
Average round size
The average size of a deal this fund participated in
Portfolio companies 132
Rounds per year 8.79
Lead investments 35
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 27
Key employees 18
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Internet
  • E-Commerce
  • Biotechnology
  • Medical

In 2002 was created CDH Investments, which is appeared as Corporate Investor. The venture was found in Asia in Hong Kong. The main department of described Corporate Investor is located in the Kowloon City.

Besides them, we counted 16 critical employees of this fund in our database.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight, Zhong An, Koubei. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are E-Commerce, Information Technology.

The real fund results show that this Corporate Investor is 19 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2018. The fund is constantly included in 7-12 investment rounds annually. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The typical startup value when the investment from CDH Investments is more than 1 billion dollars. Opposing the other organizations, this CDH Investments works on 14 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 50 - 100 millions dollars.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the CDH Investments, startups are often financed by Qiming Venture Partners, Tencent Holdings, Source Code Capital. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Qiming Venture Partners, Sequoia Capital China. In the next rounds fund is usually obtained by Qiming Venture Partners, IDG Capital, Ctrip.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CDH Investments:
Typical Co-investors
CDH Investments is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CDH Investments:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Vision Medicals

Health Care
$46M25 Nov 2021 Yuexiu District, Guangdong Province, China

RootPath Genomics

$50M07 Sep 2021 Cambridge, Massachusetts, United States


23 Jul 2021 Mountain View, California, United States

Wuye Banmian

Food and Beverage
$46M24 Jun 2021 Harbin, Heilongjiang, China

Qitan Technology

Health Care
$61M08 Jun 2021 Qingyang District, Sichuan, China

Dian Xiaomi

Service Industry
$20M02 Jun 2021 Longgang District, Guangdong Province, China


Customer Service
Supply Chain Management
17 May 2021 Dongcheng District, Beijing, China

Health Care
$105M13 May 2021 Shanghai, China

Nice Tuan

Consumer Goods
Food and Beverage
$750M31 Mar 2021 Dongcheng District, Beijing, China
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies

– IASO Biotherapeutics announced the completion of $108m Series C to advance the global development of novel cell therapies and biologics for oncology and autoimmune diseases.
– The round was led by CDH Baifu, and followed by CCB International, with strong participation from Everbright Limited, Co-Stone Capital, CNCB Capital and Plaisance Capital.
– Current shareholder GL Ventures also participated.
– Since its founding in 2017, IASO Bio has raised more than $178m.
– Proceeds from the financing will be used to accelerate the global development and regulatory submissions of multiple novel cell therapies.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CDH Investments?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: